Spectra Optia Apheresis System 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Terumo BCT 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-08-23
  • 사례 출판 날짜
    2013-08-23
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: terumo bct spectra optia apheresis system medical device manufacturer, terumo bct, inc., has issued a field safety notice concerning spectra optia apheresis system. terumo bct has modified the spectra optia system’s standard filler in order to reduce the incidence of leaks in the channel of the tubing set during mononuclear cell (mnc) collection procedures. leaks in the channel of the tubing set have many different causes. the manufacturer has identified a very specific type of channel leak caused by a pinhole-sized tear in the soft vinyl wall near the set’s hard plastic connector. this type of leak has occurred primarily during long mnc collection procedures and results in a minor blood spill that remains fully contained within the system’s centrifuge chamber. although the reported incidence of this type of channel leak is quite low (< 0.23% in spectra optia collection sets manufactured since july, 2010) and no serious adverse events have been reported, even a small tubing set leak can result in the premature termination of an apheresis procedure. consequently, terumo bct has modified and strengthened the system’s standard filler to better support the tubing set during centrifugation. according to the manufacturer, to help identify the modified filler, “spectra optia” is engraved on the top side of the filler. terumo bct will provide one modified standard filler for each device to all customers who use the system to perform mnc collection procedures. the manufacturer will begin installing the modified filler over a 12-month period, with the installation likely occurring during a scheduled preventive maintenance visit. the machine’s original filler will be removed from facility for recycling/disposal. according to the local supplier, the affected products were distributed in hong kong. if you are in possession of the products, please contact your supplier for necessary actions. posted on 23 august 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Terumo BCT Spectra Optia Apheresis Systems
  • Manufacturer

Manufacturer